Volume 18, Issue 8, Pages (August 2010)

Slides:



Advertisements
Similar presentations
Volume 184, Issue 4, Pages (October 2010)
Advertisements

MRI-Based Detection of Alkaline Phosphatase Gene Reporter Activity Using a Porphyrin Solubility Switch  Gil G. Westmeyer, Yelena Emer, Jutta Lintelmann,
Molecular Therapy - Methods & Clinical Development
Volume 8, Issue 2, Pages (August 2003)
A MicroRNA124 Target Sequence Restores Astrocyte Specificity of gfaABC1D-Driven Transgene Expression in AAV-Mediated Gene Transfer  Grit Taschenberger,
Volume 22, Issue 4, Pages (April 2014)
VEGF Gene Delivery to Muscle
Molecular Therapy - Methods & Clinical Development
Volume 22, Issue 8, Pages (August 2014)
Direct Conversion of Skin Cells into Blood: Alchemy or Science?
Volume 19, Issue 4, Pages (April 2011)
Molecular Therapy - Methods & Clinical Development
Evolving Gene Therapy in Primary Immunodeficiency
Volume 17, Issue 2, Pages (February 2009)
Volume 12, Issue 1, Pages (July 2005)
Volume 2, Issue 5, Pages (November 2000)
Volume 18, Issue 12, Pages (December 2010)
MRI-Based Detection of Alkaline Phosphatase Gene Reporter Activity Using a Porphyrin Solubility Switch  Gil G. Westmeyer, Yelena Emer, Jutta Lintelmann,
Volume 22, Issue 1, Pages (January 1999)
Xiaoyin Xu, Zhong Yang, Qiang Liu, Yaming Wang  Molecular Therapy 
Volume 19, Issue 11, Pages (November 2011)
Volume 89, Issue 5, Pages (March 2016)
Volume 4, Issue 6, Pages (December 2001)
Parts a and b are reproduced from Valles, F. et al
Gene delivery to in situ veins: Differential effects of adenovirus and adeno-associated viral vectors  Mohammad H. Eslami, MD, Sidhu P. Gangadharan, MD,
Volume 15, Issue 2, Pages (February 2007)
Volume 18, Issue 4, Pages (April 2010)
Molecular Therapy - Methods & Clinical Development
Volume 18, Issue 11, Pages (November 2010)
Volume 13, Issue 3, Pages (March 2006)
Raymond T Bartus, Marc S Weinberg, R. Jude Samulski  Molecular Therapy 
Volume 8, Issue 2, Pages (February 2017)
Volume 22, Issue 11, Pages (November 2014)
Volume 15, Issue 1, Pages (January 2007)
Volume 24, Issue 7, Pages (July 2016)
Volume 89, Issue 5, Pages (March 2016)
Molecular Therapy  Volume 7, Issue 5, (May 2003) DOI: /S (16)
Gang Wang, Na Zhao, Ben Berkhout, Atze T Das  Molecular Therapy 
Strong Promoters Are the Key to Highly Efficient, Noninflammatory and Noncytotoxic Adenoviral-Mediated Transgene Delivery into the Brain in Vivo  Christian.
Molecular Therapy - Methods & Clinical Development
847. Eradication of Therapy-Resistant Human Prostate Tumors Using an Ultrasound Guided Site-Specific Cancer Terminator Virus Delivery Approach    Molecular.
Donna M. Martin, Yehoash Raphael  Molecular Therapy 
Molecular Therapy - Methods & Clinical Development
Volume 23, Issue 4, Pages (April 2015)
Volume 23, Issue 4, Pages (April 2015)
Oral Delivery of Protein Drugs Bioencapsulated in Plant Cells
Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain  Cassia N. Cearley, John.
Volume 20, Issue 1, Pages (January 2012)
Volume 18, Issue 5, Pages (May 2010)
Lentiviral Vector-Mediated Gene Transfer to Human Hair Follicles
In This Issue Molecular Therapy Volume 16, Issue 4, (April 2008)
Nicholas M. Kanaan, Rhyomi C. Sellnow, Sanford L
Volume 13, Issue 3, Pages (March 2006)
Volume 8, Issue 2, Pages (August 2003)
Volume 18, Issue 3, Pages (March 2010)
372. Targeted Mutagenesis of Ubiquitin-Binding Lysine Residues on the Adeno- Associated Virus (AAV)2 Capsid Improves Its Transduction Efficiency    Molecular.
The Lymphocytic Choriomeningitis Virus Envelope Glycoprotein Targets Lentiviral Gene Transfer Vector to Neural Progenitors in the Murine Brain  Colleen.
Volume 19, Issue 9, Pages (September 2011)
Volume 6, Issue 3, Pages (September 2002)
Volume 18, Issue 12, Pages (December 2010)
Volume 20, Issue 9, Pages (September 2012)
Volume 21, Issue 12, Pages (December 2013)
Volume 23, Issue 3, Pages (March 2015)
Volume 21, Issue 1, Pages (January 2013)
Fetal Brain-directed AAV Gene Therapy Results in Rapid, Robust, and Persistent Transduction of Mouse Choroid Plexus Epithelia  Marie Reine Haddad, Anthony.
Thomas Gaj, Benjamin E Epstein, David V Schaffer  Molecular Therapy 
Volume 13, Issue 1, Pages (January 2006)
Molecular Therapy - Methods & Clinical Development
Volume 22, Issue 11, Pages (November 2014)
Volume 17, Issue 2, Pages (February 2009)
Presentation transcript:

Volume 18, Issue 8, Pages 1490-1495 (August 2010) Real-time MR Imaging With Gadoteridol Predicts Distribution of Transgenes After Convection-enhanced Delivery of AAV2 Vectors  Xiaomin Su, Adrian P Kells, Ernesto Aguilar Salegio, R Mark Richardson, Piotr Hadaczek, Janine Beyer, John Bringas, Philip Pivirotto, John Forsayeth, Krystof S Bankiewicz  Molecular Therapy  Volume 18, Issue 8, Pages 1490-1495 (August 2010) DOI: 10.1038/mt.2010.114 Copyright © 2010 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 1 T1-weighted MR images with Gd RCD and 3D construction of ROI. (a–e) A series of real-time T1-weighted MR images in the coronal plane obtained at various times from the beginning to the end of infusion into the thalamus of one NHP. The volume of infusate (Vi) at the corresponding infusion time point is indicated at the bottom of each panel. Bar = 0.5 cm. (f) A 3D reconstruction of ROI based on Gd signal in the left thalamus after infusion. The volume of Gd distribution (Vd) is indicated at the bottom of the panel. AAV2, adeno-associated virus type 2; Gd, Gadoteridol; MR images, magnetic resonance images; NHP, nonhuman primate; RCD, real-time convective delivery; ROI, region of interest. Molecular Therapy 2010 18, 1490-1495DOI: (10.1038/mt.2010.114) Copyright © 2010 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 2 MRI correlation with histology in primate #1 with bilateral infusion of AAV2-GDNF into the thalamus. (a) A T1-weighted MR image of Gd distribution in the thalamus (green outline). Areas staining positive for GDNF (orange outline) of corresponding sections were transferred to the MR image for comparison. Since the left and right infusions were completed by different times, the final series of MR images for each infusion was cropped and merged in a. Infusion volume to the left and right brain was indicated at the bottom of the panel [Vi (L) and Vi (R)]. Bar = 0.5 cm. (b) Coronal histology of primate brain imaged in a shows GDNF staining in a pattern similar to that noted on MRI with Gd. Bar = 1 cm. (c) High magnification of boxed insert in b, showing GDNF-positive cells within the thalamus. Bar = 50 µm. (d,e) Areas of Gd distribution and GDNF expression on the (d) left and (e) right side of the brain in a series of MR images. AAV2, adeno-associated virus type 2; Gd, Gadoteridol; GDNF, glial cell line-derived neurotrophic factor; MRI, magnetic resonance imaging; r, correlation coefficient; ROI, region of interest. Molecular Therapy 2010 18, 1490-1495DOI: (10.1038/mt.2010.114) Copyright © 2010 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 3 MRI correlation with histology in primate #2 with unilateral coinfusion of AAV2-GDNF and AAV2-AADC into the thalamus. (a) T1-weighted MR image showing Gd distribution in the thalamus (green outline). Areas staining positive for GDNF (orange outline) and AADC (blue outline) of corresponding sections were transferred to the MR image for comparison. Bar = 0.5 cm. (b) Coronal section of primate brain imaged in a, showing GDNF staining in a pattern similar to that noted on MRI with Gd. Bar = 1 cm. (c) AADC-stained section adjacent to (b), showing both endogenous and transduced AADC expression. Transduced AADC is outlined in blue. (e) AADC and TH colabeled section adjacent to (c), showing costaining for AADC in brown and tyrosine hydroxylase (TH) in red to differentiate endogenous AADC/TH (dark red) from transduced AADC (brown). The expression pattern of transduced AADC is nearly identical to GDNF expression in b. (e) High magnification of boxed insert in c showing endogenous AADC-positive cells in the nigra. Bar = 50 µm. (f) High magnification of boxed insert in d showing AADC/TH-positive cells in the nigra. Bar = 50 µm. (g) High magnification of boxed insert in c showing endogenous AADC-positive fibers in the putamen. Bar = 50 µm. (h) High magnification of boxed insert in c showing AADC-positive cells in the putamen. Bar = 50 µm. (i) High magnification of boxed insert in d showing AADC-positive cells in the thalamus. Bar = 50 µm. (j) The areas of Gd, GDNF, and AADC distribution on the right side of the brain in a series of MR images. AADC, aromatic l-amino acid decarboxylase; AAV2, adeno-associated virus type 2; Gd, Gadoteridol; GDNF, glial cell line-derived neurotrophic factor; MRI, magnetic resonance imaging; r1, correlation coefficient between areas of Gd and GDNF expression; r2, correlation coefficient between areas of Gd and AADC expression; r3, correlation coefficient between areas of GDNF and AADC expression. Molecular Therapy 2010 18, 1490-1495DOI: (10.1038/mt.2010.114) Copyright © 2010 The American Society of Gene & Cell Therapy Terms and Conditions

Figure 4 MRI correlation with histology in primate #3 with bilateral coinfusion of AAV2-GDNF and AAV2-AADC into the thalamus. (a) T1-weighted MR image showing Gd distribution in the thalamus, outlined in green. Areas staining positive for GDNF (outlined in orange) and AADC (outlined in blue) of corresponding sections were transferred to the MR image for comparison. Bar = 0.5 cm. (b) Coronal section of primate brain imaged in a, showing GDNF staining in a pattern similar to that noted on MRI with Gd. Bar =1 cm. (c) AADC and TH colabeled section adjacent to (b), showing costaining for AADC in brown and tyrosine hydroxylase (TH) in red. (d, e) Areas of Gd, GDNF, and AADC distribution on the (d) left and (e) right side of the brain in a series of MR images. AADC, aromatic l-amino acid decarboxylase; AAV2, adeno-associated virus type 2; Gd, Gadoteridol; GDNF, glial cell line-derived neurotrophic factor; MRI, magnetic resonance imaging; r1, correlation coefficient between areas of Gd and GDNF expression; r2, correlation coefficient between areas of Gd and AADC expression; r3, correlation coefficient between areas of GDNF and AADC expression. Molecular Therapy 2010 18, 1490-1495DOI: (10.1038/mt.2010.114) Copyright © 2010 The American Society of Gene & Cell Therapy Terms and Conditions